Alternative splicing of SLAMF6 in human T cells creates a co-stimulatory isoform that counteracts the inhibitory effect of the full-length receptor
暂无分享,去创建一个
N. Hacohen | Y. Tabach | Keren Yizhak | M. Sade-Feldman | R. Karni | T. Peretz | M. Lotem | A. Veillette | P. Stepensky | A. Navon | Jonathan E. Cohen | S. Klein | Shay Tzaban | S. Merims | G. Eisenberg | S. Frankenburg | Elad Zisman | E. Hajaj | Moshe Sade-Feldman | Shiri Klein
[1] E. Hoffman,et al. Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping , 2020, JAMA neurology.
[2] N. Hacohen,et al. SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint , 2020, eLife.
[3] S. Carmona,et al. Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells , 2020, Frontiers in Immunology.
[4] John G. Doench,et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy , 2019, Nature.
[5] S. Berger,et al. TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision. , 2019, Immunity.
[6] G. Freeman,et al. PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity , 2019, Nature Immunology.
[7] Catherine J. Wu,et al. SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer , 2019, Cancer Immunology Research.
[8] K. Patrick,et al. The Splicing Factor hnRNP M Is a Critical Regulator of Innate Immune Gene Expression in Macrophages , 2019, bioRxiv.
[9] M. Rotival,et al. Defining the genetic and evolutionary architecture of alternative splicing in response to infection , 2019, Nature Communications.
[10] Yan Lu,et al. SLAM receptors foster iNKT cell development by reducing TCR signal strength after positive selection , 2019, Nature Immunology.
[11] Ziv Shulman,et al. T cell interactions with B cells during germinal center formation, a three‐step model , 2019, Immunological reviews.
[12] F. Hodi,et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2019, Nature Immunology.
[13] Paul J. Hoover,et al. Erratum: Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma (Cell (2018) 175(4) (998–1013.e20), (S0092867418313941) (10.1016/j.cell.2018.10.038)) , 2019 .
[14] Paul J. Hoover,et al. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma , 2019, Cell.
[15] K. E. Lundin,et al. Chemical Development of Therapeutic Oligonucleotides. , 2019, Methods in molecular biology.
[16] Paul J. Hoover,et al. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma , 2018, Cell.
[17] Bin Zhang,et al. ARID5B regulates metabolic programming in human adaptive NK cells , 2018, The Journal of experimental medicine.
[18] J. Cannons,et al. X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective , 2018, Front. Immunol..
[19] R. Finkel,et al. Nusinersen versus Sham Control in Later‐Onset Spinal Muscular Atrophy , 2018, The New England journal of medicine.
[20] T. Peretz,et al. Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo , 2018, Cancer Immunology Research.
[21] B. Ueberheide,et al. Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor , 2017, Proceedings of the National Academy of Sciences.
[22] Chun Jimmie Ye,et al. Genetic analysis of isoform usage in the human anti-viral response reveals influenza-specific regulation of ERAP2 transcripts under balancing selection , 2017, bioRxiv.
[23] Z. Siegfried,et al. The role of RNA alternative splicing in regulating cancer metabolism , 2017, Human Genetics.
[24] Ning Wu,et al. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1 , 2016, The Journal of experimental medicine.
[25] Ning Wu,et al. Correction: Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1 , 2016, The Journal of experimental medicine.
[26] Mallory A. Havens,et al. Splice-switching antisense oligonucleotides as therapeutic drugs , 2016, Nucleic acids research.
[27] Charles H. Yoon,et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.
[28] Ben-Ari FuchsShani,et al. GeneAnalytics: An Integrative Gene Set Analysis Tool for Next Generation Sequencing, RNAseq and Microarray Data , 2016 .
[29] Doron Lancet,et al. GeneAnalytics: An Integrative Gene Set Analysis Tool for Next Generation Sequencing, RNAseq and Microarray Data , 2016, Omics : a journal of integrative biology.
[30] C. Lenoir,et al. A hematopoietic cell–driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education , 2016, Nature Immunology.
[31] Ning Wu,et al. SLAM family receptors in normal immunity and immune pathologies. , 2016, Current opinion in immunology.
[32] Wen J. Li,et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation , 2015, Nucleic Acids Res..
[33] A. Porgador,et al. First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue , 2015, Front. Immunol..
[34] Yiming Bao,et al. NCBI Viral Genomes Resource , 2014, Nucleic Acids Res..
[35] D. Bates,et al. Hallmarks of alternative splicing in cancer , 2014, Oncogene.
[36] V. Cetica,et al. XLP1 inhibitory effect by 2B4 does not affect DNAM‐1 and NKG2D activating pathways in NK cells , 2014, European journal of immunology.
[37] David C. Smith,et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] David A. Scott,et al. Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.
[39] Henry H. Paik,et al. Differential splicing across immune system lineages , 2013, Proceedings of the National Academy of Sciences.
[40] O. Mühlemann,et al. Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells. , 2013, Biochimica et biophysica acta.
[41] A. Burghes,et al. Antisense oligonucleotides for the treatment of spinal muscular atrophy. , 2013, Human gene therapy.
[42] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[43] Sven Rahmann,et al. Snakemake--a scalable bioinformatics workflow engine. , 2012, Bioinformatics.
[44] Bruce M. Wentworth,et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy , 2012, Nature.
[45] S. Crotty,et al. The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development. , 2012, Immunity.
[46] J. Cannons,et al. Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis. , 2012, Immunity.
[47] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[48] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[49] S. Tangye,et al. SLAM family receptors and SAP adaptors in immunity. , 2011, Annual review of immunology.
[50] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[51] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[52] A. Veillette. SLAM-family receptors: immune regulators with or without SAP-family adaptors. , 2010, Cold Spring Harbor perspectives in biology.
[53] K. Nichols,et al. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. , 2009, The Journal of clinical investigation.
[54] N. Hacohen,et al. Regulation of CD45 Alternative Splicing by Heterogeneous Ribonucleoprotein, hnRNPLL , 2008, Science.
[55] A. Veillette,et al. Control of T Lymphocyte Signaling by Ly108, a Signaling Lymphocytic Activation Molecule Family Receptor Implicated in Autoimmunity* , 2008, Journal of Biological Chemistry.
[56] P. Engel,et al. The SLAM and SAP gene families control innate and adaptive immune responses. , 2008, Advances in immunology.
[57] S. Rietdijk,et al. The SLAM-associated protein signaling pathway is required for development of CD4+ T cells selected by homotypic thymocyte interaction. , 2007, Immunity.
[58] C. Mohan,et al. Regulation of B Cell Tolerance by the Lupus Susceptibility Gene Ly108 , 2006, Science.
[59] Transfection of mammalian cells by electroporation , 2006, Nature Methods.
[60] Eric O Long,et al. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). , 2005, Blood.
[61] R. Clementi,et al. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. , 2005, Blood.
[62] C. June,et al. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation1 , 2004, The Journal of Immunology.
[63] P. Schwartzberg,et al. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation , 2003, Nature Cell Biology.
[64] Qiong Shen,et al. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family , 2002, Immunogenetics.
[65] Massimo Morra,et al. Structural basis for the interaction of the free SH2 domain EAT‐2 with SLAM receptors in hematopoietic cells , 2001, The EMBO journal.
[66] L. Notarangelo,et al. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. , 2001, The Journal of experimental medicine.
[67] T. Pawson,et al. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product , 2001, Nature Immunology.
[68] K. Nichols,et al. CD150 Association with Either the SH2-Containing Inositol Phosphatase or the SH2-Containing Protein Tyrosine Phosphatase Is Regulated by the Adaptor Protein SH2D1A1 , 2001, The Journal of Immunology.